Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and Bone Loss, Osteoclastic

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bijvoet, OL; Hoekman, K; Löwik, CW; Papapoulos, SE; van de Ruit, M; Verheijen, JH1
Gustafson, GT; Lerner, UH1

Other Studies

2 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Bone Loss, Osteoclastic

ArticleYear
The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
    Bone and mineral, 1992, Volume: 17, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Analysis of Variance; Animals; Bone Resorption; Calcium; Culture Techniques; Female; Fibrinolysin; Mice; Mutation; Osteoclasts; Pregnancy; Recombinant Proteins; Tissue Plasminogen Activator; Transforming Growth Factor alpha

1992
Inhibition of bone resorption in vitro by serine-esterase inhibitors.
    Biochimica et biophysica acta, 1988, Feb-17, Volume: 964, Issue:2

    Topics: Acetylglucosaminidase; Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcium; Esterases; Glucuronidase; Hydroxycholecalciferols; Hydroxyproline; L-Lactate Dehydrogenase; Mice; Organ Culture Techniques; Parathyroid Hormone; Phenylalanine; Phosphates; Piperidines

1988